Doctor of Philosophy University of South Australia
Master of Science (Clinical Pharmacy) Jimma University
Bachelor of Pharmacy Mekelle University
Excludes commercial-in-confidence projects.
Research outputs for the last seven years are shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
Anshabo, AT, Bantie, L, Diab, S, Lenjisa, J, Kebede, A, Long, Y, Heinemann, G, Karanjia, J, Noll, B, Basnet, SK, Li, M, Milne, R, Albrecht, H & Wang, S 2022, 'An orally bioavailable and highly efficacious inhibitor of CDK9/FLT3 for the treatment of acute myeloid leukemia', Cancers, vol. 14, no. 5, article no. 1113, pp. 1-19.
Bantie, L, Tadesse, S, Likisa, J, Yu, M, Noll, B, Heinemann, G, Lokman, NA, Ricciardelli, C, Oehler, MK, Beck, A, Pradhan, R, Milne, R, Albrecht, H & Wang, S 2020, 'A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer', Gynecologic Oncology, vol. 159, no. 3, pp. 827-838.
5 6 1
Supervisions from 2010 shown
|Thesis title||Student status|
|CDK inhibitors as immunotherapeutic agents for cancer treatment||Current|
|Development of Cyclin Dependent Kinase Inhibitors for Cancer Treatment||Current|